SIMULTANEOUS IRRADIATION FOR PROSTATE CANCER: INTERMEDIATE RESULTS WITH MODERN TECHNIQUES
- 1 September 2000
- journal article
- Published by Ovid Technologies (Wolters Kluwer Health) in Journal of Urology
- Vol. 164 (3 Part 1), 738-743
- https://doi.org/10.1016/s0022-5347(05)67293-x
Abstract
No abstract availableThis publication has 14 references indexed in Scilit:
- Post-treatment PSA ≤0.2 ng/ml defines disease freedom after radiotherapy for prostate cancer using modern techniquesUrology, 1999
- Treatment Options for Localized Prostate Cancer Based on Pretreatment Serum Prostate Specific Antigen LevelsJournal of Urology, 1997
- Long-Term Results of Retropubic Permanent 125 Iodine Implantation of the Prostate for Clinically Localized Prostatic CancerJournal of Urology, 1997
- Results of 3D conformal radiotherapy in the treatment of localized prostate cancerInternational Journal of Radiation Oncology*Biology*Physics, 1997
- Biochemical disease-free survival following 125I prostate implantationInternational Journal of Radiation Oncology*Biology*Physics, 1997
- Prostate-specific antigen nadir: the optimum level after irradiation for prostate cancer.Journal of Clinical Oncology, 1996
- Tumor control and morbidity following transperineal iodine 125 implantation for stage T1/T2 prostatic carcinoma.Journal of Clinical Oncology, 1996
- Prostate Specific Antigen Based Disease Control Following Ultrasound Guided sup 125 Iodine Implantation for Stage T1/T2 Prostatic CarcinomaJournal of Urology, 1995
- Clinical and Biochemical Evidence of Control of Prostate Cancer at 5 Years After External Beam RadiationJournal of Urology, 1995
- Retropubic Implantation of Iodine 125 in the Treatment of Prostatic CancerJournal of Urology, 1972